Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Benzeneacetamide, 4-[2-hydroxy-3-[[1-(methyl-d3)ethyl-1,2,2,2-d4]amino]propoxy]- | 1202864-50-3 | 99.6% | 273.38 | 5 MG
SDP

Catalog No. 5000386608
Encompass_Preferred

Atenolol-d7 is a deuterium-labeled version of Atenolol. Atenolol itself is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at the β1-adrenoceptor in guinea pig left ventricle membrane. It is utilized in the research of hypertension and angina pectoris. Deuteration, the process of incorporating stable heavy isotopes like deuterium into drug molecules, is largely employed as a tracer for quantitation during drug development and is known for its potential to influence the pharmacokinetic and metabolic profiles of drugs. This compound is intended for research use only.

  • Deuterium labeled, suitable for use as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
  • Cardioselective β1-adrenergic receptor blocker.
  • Potential to affect pharmacokinetic and metabolic profiles of drugs due to deuteration.

Catalog No. 50-003-86608 Supplier Medchemexpress LLC Supplier No. HY17498S5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Atenolol-d7 is a deuterium-labeled version of Atenolol. Atenolol itself is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at the β1-adrenoceptor in guinea pig left ventricle membrane. It is utilized in the research of hypertension and angina pectoris. Deuteration, the process of incorporating stable heavy isotopes like deuterium into drug molecules, is largely employed as a tracer for quantitation during drug development and is known for its potential to influence the pharmacokinetic and metabolic profiles of drugs. This compound is intended for research use only.

  • Deuterium labeled, suitable for use as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
  • Cardioselective β1-adrenergic receptor blocker.
  • Potential to affect pharmacokinetic and metabolic profiles of drugs due to deuteration.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.